Tilray Brands, Inc. (TLRY) |
|
2.4 0 (0%)
|
09-27 16:00 |
|
Open: |
2.5 |
Pre. Close: |
2.4 |
|
High:
|
2.62 |
Low:
|
2.31 |
|
Volume:
|
34,065,493 |
Market Cap:
|
1,688(M) |
|
|
|
Technical analysis |
as of: 2023-09-27 4:22:32 PM |
|
Short-term rate:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
|
Mid-term rate:
|
|
| Target: |
Six months: 3.44 One year: 3.97 |
| Support: |
Support1: 2.22 Support2: 1.84 |
| Resistance: |
Resistance1: 2.94 Resistance2: 3.4 |
| Pivot: |
2.71 |
| Moving Average: |
MA(5): 2.43 MA(20): 2.76
MA(100): 2.21 MA(250): 2.72 |
| MACD: |
MACD(12,26): -0.1 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 12  %D(3): 11.1 |
| RSI: |
RSI(14): 43.1 |
| 52-week: |
High: 5.11 Low: 1.5 |
| Average Vol(K): |
3-Month: 32,734 (K) 10-Days: 30,091 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ TLRY ] has closed above bottom band by 23.4%. Bollinger Bands are 47.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.62 - 2.63 |
2.63 - 2.65 |
|
Low:
|
2.28 - 2.29 |
2.29 - 2.31 |
|
Close:
|
2.38 - 2.4 |
2.4 - 2.42 |
|
Company Description |
|
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada. |
Headline News |
Wed, 27 Sep 2023
Tilray Brands Inc. stock remains steady Wednesday, underperforms market - MarketWatch
Wed, 27 Sep 2023
Cannabis stock gains fade in volatile trading on US Senate bill hopes - Reuters
Wed, 27 Sep 2023
Tilray Brands Inc (TLRY) is up 0.83% Wednesday In Premarket Trading - InvestorsObserver
Wed, 27 Sep 2023
Tilray (TLRY) to Release Quarterly Earnings on Wednesday - MarketBeat
Wed, 27 Sep 2023
Is Tilray (TLRY) Worthy of Being the Most Shorted Cannabis Stock? - TheStreet
Tue, 12 Sep 2023
Investors Are Bullish On This Pot Stock: Should You Hold Tilray Brands Inc (TLRY) Tuesday? - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
720 (M) |
| Shares Float |
691 (M) |
|
% Held by Insiders
|
1.3 (%) |
|
% Held by Institutions
|
10 (%) |
|
Shares Short
|
89,130 (K) |
|
Shares Short P.Month
|
83,930 (K) |
Stock Financials |
|
EPS
|
-2.27 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
5.05 |
|
Profit Margin (%)
|
-231.7 |
|
Operating Margin (%)
|
-28.8 |
|
Return on Assets (ttm)
|
-2.4 |
|
Return on Equity (ttm)
|
-37.2 |
|
Qtrly Rev. Growth
|
20.1 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0.87 |
|
EBITDA (p.s.)
|
-0.07 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
8 (M) |
|
Levered Free Cash Flow
|
91 (M) |
Stock Valuations |
|
PE Ratio
|
-1.06 |
|
PEG Ratio
|
-0.3 |
|
Price to Book value
|
0.47 |
|
Price to Sales
|
2.75 |
|
Price to Cash Flow
|
218.58 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
